menu
    • menu

    Company profile for OnCusp Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    OnCusp Therapeutics is a developer of innovative oncology therapies designed to innovate treatments that deliver help and hope to cancer patients worldwide. The company is dedicated to the translation and clinical development of oncology therapeutics, with a focus to bring preclinical drug candidates (PCCs) to the clinical proof-of-concept (POC) stage and then advance these assets into global early clinical development to quic...
    OnCusp Therapeutics is a developer of innovative oncology therapies designed to innovate treatments that deliver help and hope to cancer patients worldwide. The company is dedicated to the translation and clinical development of oncology therapeutics, with a focus to bring preclinical drug candidates (PCCs) to the clinical proof-of-concept (POC) stage and then advance these assets into global early clinical development to quickly establish POC, enabling healthcare companies to commercialize drug candidates in the global market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OnCusp TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    433 Broadway, New York, NY 10013
    Telephone
    Telephone
    +1 6465852168
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oncusptx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oncusp-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OnCusp Therapeutics Reports Positive Ph 1a Results at 2025 ASCO
    OnCusp Therapeutics Reports Positive Ph 1a Results at 2025 ASCO

    02 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncusp-therapeutics-announces-encouraging-initial-phase-1a-results-from-ongoing-first-in-human-study-evaluating-its-cdh6-directed-antibody-drug-conjugate-cusp06-in-platinum-refractoryresistant-ovarian-cancer-and-other-advanced--302470621.html

    PR NEWSWIRE
    02 Jun 2025
    Share Share
    OnCusp Gets FDA Fast Track For CUSP06 In Platinum-Resistant Cancer
    OnCusp Gets FDA Fast Track For CUSP06 In Platinum-Resistant Cancer

    12 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncusp-therapeutics-receives-fda-fast-track-designation-for-cusp06-for-the-treatment-of-platinum-resistant-ovarian-cancer-302374728.html

    PR NEWSWIRE
    12 Feb 2025
    Share Share
    OnCusp’s CUSP06 Receives FDA Fast Track Designation
    OnCusp’s CUSP06 Receives FDA Fast Track Designation

    11 Feb 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/oncusps-cusp06-receives-fda-fast-track-designation/

    CONTRACTPHARMA
    11 Feb 2025
    Share Share
    OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing
    OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing

    04 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncusp-therapeutics-raises-oversubscribed-100-million-series-a-financing-to-advance-portfolio-of-assets-for-cancer-patients-302026328.html

    PR NEWSWIRE
    04 Jan 2024
    Share Share
    OnCusp Therapeutics Receives FDA Clearance for Phase 1 Clinical Trial of CUSP06
    OnCusp Therapeutics Receives FDA Clearance for Phase 1 Clinical Trial of CUSP06

    15 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncusp-therapeutics-receives-fda-clearance-for-the-phase-1-clinical-trial-of-cusp06-targeting-ovarian-cancer-and-other-advanced-solid-tumors-301900741.html

    PR NEWSWIRE
    15 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search